Early Impact of the State Innovation Models Initiative on Diagnosed Diabetes Prevalence Among Adults and Hospitalizations Among Diagnosed Adults
Datos Bibliográficos
| ID | 9102962 |
|---|---|
| Autores | Brent D Fulton (0000-0002-8305-4711, Health Economics and Policy, School of Public Health, autor de correspondencia), Nianyi Hong (School of Public Health), Hector P Rodriguez (0000-0002-6564-2229, Henry J. Kaiser Endowed Chair in Organized Health Systems, School of Public Health, University of California, Berkeley, Berkeley, CA) |
| Año | 2019 |
| Volumen | 57 |
| Número | 9 |
| Páginas | 710-717 |
| Fecha de publicación | 2019-09-01 |
| Peer Reviewed | Sí |
| Open Access | No |
| Tipo | ARTICLE |
| Revista | Medical Care (JOURNAL) |
| Identificadores de la revista | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editorial | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/mlr.0000000000001161 |
| PMID | 31295167 |
| OpenAlex | W2962569726 |
| Idioma | EN |
| Citas recibidas | 2 |
| Referencias citadas | 22 |
BACKGROUND: The State Innovation Models (SIM) Initiative invested $254 million in 6 states in Round 1 to accelerate delivery system and payment reforms. OBJECTIVE: The objective of this study was to examine the association of early SIM implementation and diagnosed diabetes prevalence among adults and hospitalization rates among diagnosed adults. RESEARCH DESIGN: Quasi-experimental design compares diagnosed diabetes prevalence and hospitalization rates before SIM (2010-2013) and during early implementation (2014) in 6 SIM states versus 6 comparison states. County-level, difference-in-differences regression models were estimated. SUBJECTS: The annual average of 4.5 million adults aged 20+ diagnosed with diabetes with 1.4 million hospitalizations in 583 counties across 12 states. MEASURES: Diagnosed diabetes prevalence among adults and hospitalization rates per 1000 diagnosed adults. RESULTS: Compared with the pre-SIM period, diagnosed diabetes prevalence increased in SIM counties by 0.65 percentage points (from 10.22% to 10.87%) versus only 0.10 percentage points (from 9.64% to 9.74%) in comparison counties, a difference-in-differences of 0.55 percentage points. The difference-in-differences regression estimates ranged from 0.49 to 0.53 percentage points (P<0.01). Regression results for ambulatory care-sensitive condition and all-cause hospitalization rates were inconsistent across models with difference-in-differences estimates ranging from -5.34 to -0.37 and from -13.16 to 0.92, respectively. CONCLUSIONS: SIM Round 1 was associated with higher diagnosed diabetes prevalence among adults after a year of implementation, likely because of SIM's emphasis on detection and care management. SIM was not associated with lower hospitalization rates among adults diagnosed with diabetes, but the SIM's long-term impact on hospitalizations should be assessed
Ambulatory · Diabetes mellitus · Percentage point · Statistics · Young adult · Chronic Disease Management Strategies · Demography · Diabetes Management and Education · Health Policy Implementation Science · Internal Medicine · Medicine · Gerontology · Pediatrics
Doubly Robust Estimation in Missing Data and Causal Inference Models
Economic Costs of Diabetes in the U.S. in 2017
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
Methods for Constructing and Assessing Propensity Scores
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
The central role of the propensity score in observational studies for causal effects
How Much Should We Trust Differences-In-Differences Estimates?
| Obras citantes distintas | 2 |
|---|---|
| Citas por año | 0,33 |
| Intervalo de citas | 2020 - 2021 (2) |
| Velocidad de citación | historical |
| Altamente citado | No |
| Tipos de cita | Neutras: 1 |